Annual ROE
-28.61%
-7.01%-32.45%
31 December 2023
Summary:
Compass Therapeutics annual return on equity is currently -28.61%, with the most recent change of -7.01% (-32.45%) on 31 December 2023. During the last 3 years, it has risen by +45.24% (+61.26%). CMPX annual ROE is now -163.35% below its all-time high of 45.16%, reached on 01 December 2018.CMPX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-32.37%
-1.48%-4.79%
01 September 2024
Summary:
Compass Therapeutics quarterly return on equity is currently -32.37%, with the most recent change of -1.48% (-4.79%) on 01 September 2024. Over the past year, it has dropped by -8.63% (-36.35%). CMPX quarterly ROE is now -107.03% below its all-time high of 460.33%, reached on 01 September 2020.CMPX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CMPX ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.5% | -36.4% |
| 3 y3 years | +61.3% | +86.8% |
| 5 y5 years | -163.3% | - |
CMPX ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -32.5% | +61.3% | -36.4% | +86.8% |
| 5 y | 5 years | -163.3% | +61.3% | -107.0% | +86.8% |
| alltime | all time | -163.3% | +61.3% | -107.0% | +86.8% |
Compass Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -32.37%(+4.8%) |
| June 2024 | - | -30.89%(+7.7%) |
| Mar 2024 | - | -28.67%(+10.0%) |
| Dec 2023 | -28.61%(+32.5%) | -26.06%(+9.8%) |
| Sept 2023 | - | -23.74%(-10.8%) |
| June 2023 | - | -26.62%(+0.1%) |
| Mar 2023 | - | -26.60%(-5.2%) |
| Dec 2022 | -21.60%(-63.2%) | -28.06%(-10.6%) |
| Sept 2022 | - | -31.38%(-3.6%) |
| June 2022 | - | -32.55%(-67.5%) |
| Mar 2022 | - | -100.11% |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | -58.67%(-20.6%) | - |
| Dec 2021 | - | -145.25%(-40.9%) |
| Sept 2021 | - | -245.97%(+13.9%) |
| June 2021 | - | -215.99%(+207.8%) |
| Mar 2021 | - | -70.18%(+11.4%) |
| Dec 2020 | -73.85%(-352.1%) | -63.00%(-113.7%) |
| Sept 2020 | - | 460.33%(+454.6%) |
| June 2020 | - | 83.00%(+224.1%) |
| Mar 2020 | - | 25.61%(+26.7%) |
| Dec 2019 | 29.29%(-35.1%) | 20.21% |
| Dec 2018 | 45.16% | - |
FAQ
- What is Compass Therapeutics annual return on equity?
- What is the all time high annual ROE for Compass Therapeutics?
- What is Compass Therapeutics annual ROE year-on-year change?
- What is Compass Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Compass Therapeutics?
- What is Compass Therapeutics quarterly ROE year-on-year change?
What is Compass Therapeutics annual return on equity?
The current annual ROE of CMPX is -28.61%
What is the all time high annual ROE for Compass Therapeutics?
Compass Therapeutics all-time high annual return on equity is 45.16%
What is Compass Therapeutics annual ROE year-on-year change?
Over the past year, CMPX annual return on equity has changed by -7.01% (-32.45%)
What is Compass Therapeutics quarterly return on equity?
The current quarterly ROE of CMPX is -32.37%
What is the all time high quarterly ROE for Compass Therapeutics?
Compass Therapeutics all-time high quarterly return on equity is 460.33%
What is Compass Therapeutics quarterly ROE year-on-year change?
Over the past year, CMPX quarterly return on equity has changed by -8.63% (-36.35%)